These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19661086)

  • 1. Circulating estrogen metabolites and risk for breast cancer in premenopausal women.
    Arslan AA; Shore RE; Afanasyeva Y; Koenig KL; Toniolo P; Zeleniuch-Jacquotte A
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2273-9. PubMed ID: 19661086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
    Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
    Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.
    Arslan AA; Koenig KL; Lenner P; Afanasyeva Y; Shore RE; Chen Y; Lundin E; Toniolo P; Hallmans G; Zeleniuch-Jacquotte A
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1290-7. PubMed ID: 24769889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups.
    Jernström H; Klug TL; Sepkovic DW; Bradlow HL; Narod SA
    Carcinogenesis; 2003 May; 24(5):991-1005. PubMed ID: 12771045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer.
    Zeleniuch-Jacquotte A; Shore RE; Afanasyeva Y; Lukanova A; Sieri S; Koenig KL; Idahl A; Krogh V; Liu M; Ohlson N; Muti P; Arslan AA; Lenner P; Berrino F; Hallmans G; Toniolo P; Lundin E
    Br J Cancer; 2011 Oct; 105(9):1458-64. PubMed ID: 21952628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
    Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
    Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen metabolites and the risk of breast cancer in older women.
    Cauley JA; Zmuda JM; Danielson ME; Ljung BM; Bauer DC; Cummings SR; Kuller LH
    Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense
    Green T; See J; Schauch M; Reil J; Glover M; Brix J; Gerry A; Li K; Newman M; Gahler RJ; Wood S
    J Complement Integr Med; 2023 Mar; 20(1):199-206. PubMed ID: 36201753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones.
    Lu LJ; Cree M; Josyula S; Nagamani M; Grady JJ; Anderson KE
    Cancer Res; 2000 Mar; 60(5):1299-305. PubMed ID: 10728690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2-/16α-Hydroxylated Estrogen Ratio-Breast Cancer Risk Hypothesis: Insufficient Evidence for its Support.
    Stanczyk FZ
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105685. PubMed ID: 32320758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
    Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
    J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States).
    Bentz AT; Schneider CM; Westerlind KC
    Cancer Causes Control; 2005 May; 16(4):455-61. PubMed ID: 15953988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of urinary estrogen metabolites with mammographic densities in premenopausal women.
    Maskarinec G; Heak S; Morimoto Y; Custer L; Franke AA
    Cancer Epidemiol; 2012 Oct; 36(5):e310-6. PubMed ID: 22537763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
    Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E
    Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
    Ruan X; Seeger H; Wallwiener D; Huober J; Mueck AO
    Arch Gynecol Obstet; 2015 May; 291(5):1141-6. PubMed ID: 25318606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?
    Obi N; Vrieling A; Heinz J; Chang-Claude J
    Int J Womens Health; 2011 Feb; 3():37-51. PubMed ID: 21339936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy.
    Oh H; Khodr ZG; Sherman ME; Palakal M; Pfeiffer RM; Linville L; Geller BM; Vacek PM; Weaver DL; Chicoine RE; Falk RT; Horne HN; Papathomas D; Patel DA; Xiang J; Xu X; Veenstra T; Hewitt SM; Shepherd JA; Brinton LA; Figueroa JD; Gierach GL
    Horm Cancer; 2016 Dec; 7(5-6):305-315. PubMed ID: 27138982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnicity, body size, and estrogen levels in postmenopausal Hispanic and non-Hispanic white women.
    Wacker M; Risendal B; Westerlind K; Lezotte D; Byers T
    J Womens Health (Larchmt); 2009 Apr; 18(4):487-91. PubMed ID: 19361315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.
    Ziegler RG; Rossi SC; Fears TR; Bradlow HL; Adlercreutz H; Sepkovic D; Kiuru P; Wahala K; Vaught JB; Donaldson JL; Falk RT; Fillmore CM; Siiteri PK; Hoover RN; Gail MH
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):607-14. PubMed ID: 9168003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fiber and serum 16α-hydroxyestrone, an estrogen metabolite associated with lower systolic blood pressure.
    Patel S; Hawkley LC; Cacioppo JT; Masi CM
    Nutrition; 2011; 27(7-8):778-81. PubMed ID: 21035306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.